Musculoskeletal disease burden of hereditary hemochromatosis
- PMID: 20722017
- DOI: 10.1002/art.27712
Musculoskeletal disease burden of hereditary hemochromatosis
Abstract
Objective: To determine the prevalence, clinical picture, and disease burden of arthritis in patients with hereditary hemochromatosis.
Methods: In this cross-sectional observational study of 199 patients with hemochromatosis and iron overload, demographic and disease-specific variables, genotype, and organ involvement were recorded. The prevalence, intensity, and localization of joint pain were assessed, and a complete rheumatologic investigation was performed. Radiographs of the hands, knees, and ankles were scored for joint space narrowing, erosions, osteophytes, and chondrocalcinosis. In addition, the number and type of joint replacement surgeries were recorded.
Results: Joint pain was reported by 72.4% of the patients. Their mean ± SD age at the time of the initial joint symptoms was 45.8 ± 13.2 years. If joint pain was present, it preceded the diagnosis of hemochromatosis by a mean ± SD of 9.0 ± 10.7 years. Bony enlargement was observed in 65.8% of the patients, whereas synovitis was less common (13.6%). Joint space narrowing and osteophytes as well as chondrocalcinosis of the wrist and knee joints were frequent radiographic features of hemochromatosis. Joint replacement surgery was common, with 32 patients (16.1%) undergoing total joint replacement surgery due to severe OA. The mean ± SD age of these patients was 58.3 ± 10.4 years at time of joint replacement surgery. Female sex, metacarpophalangeal joint involvement, and the presence of chondrocalcinosis were associated with a higher risk of early joint failure (i.e., the need for joint replacement surgery).
Conclusion: Arthritis is a frequent, early, and severe symptom of hemochromatosis. Disease is not confined to involvement of the metacarpophalangeal joints and often leads to severe damage requiring the replacement of joints.
Copyright © 2010 by the American College of Rheumatology.
Similar articles
-
HFE-related hemochromatosis: an update for the rheumatologist.Curr Rheumatol Rep. 2014 Jan;16(1):393. doi: 10.1007/s11926-013-0393-4. Curr Rheumatol Rep. 2014. PMID: 24264720 Review.
-
Hereditary hemochromatosis as a risk factor for joint replacement surgery.Am J Med. 2010 Jul;123(7):659-62. doi: 10.1016/j.amjmed.2010.01.024. Am J Med. 2010. PMID: 20609690
-
The arthropathy of hemochromatosis.Radiology. 1976 Mar;118(3):591-6. doi: 10.1148/118.3.591. Radiology. 1976. PMID: 175396
-
Arthritis in hemochromatosis.J Rheumatol. 1993 Mar;20(3):448-52. J Rheumatol. 1993. PMID: 8478850
-
[Arthropathy due to hemochromatosis: often inaugural manifestation of the disease].Schweiz Med Wochenschr. 1992 May 30;122(22):842-9. Schweiz Med Wochenschr. 1992. PMID: 1604289 Review. French.
Cited by
-
Age-dependent ferritin elevations and HFE C282Y mutation as risk factors for symptomatic knee osteoarthritis in males: a longitudinal cohort study.BMC Musculoskelet Disord. 2014 Jan 8;15:8. doi: 10.1186/1471-2474-15-8. BMC Musculoskelet Disord. 2014. PMID: 24401005 Free PMC article.
-
HFE-related hemochromatosis: an update for the rheumatologist.Curr Rheumatol Rep. 2014 Jan;16(1):393. doi: 10.1007/s11926-013-0393-4. Curr Rheumatol Rep. 2014. PMID: 24264720 Review.
-
Haemochromatosis patients' research priorities: Towards an improved quality of life.Health Expect. 2023 Dec;26(6):2293-2301. doi: 10.1111/hex.13830. Epub 2023 Jul 28. Health Expect. 2023. PMID: 37503783 Free PMC article.
-
Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank.BMJ. 2019 Jan 16;364:k5222. doi: 10.1136/bmj.k5222. BMJ. 2019. PMID: 30651232 Free PMC article.
-
[Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases?].Orthopade. 2019 Nov;48(11):949-956. doi: 10.1007/s00132-019-03805-7. Orthopade. 2019. PMID: 31515589 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical